NYBC Ventures
North America, Massachusetts, United States, Boston
Description
NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies.
Investor Profile
NYBC Ventures has backed more than 14 startups, with 2 new investments in the last 12 months alone. The firm has led 6 rounds, about 43% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Seed (43%)
- Series Unknown (36%)
- Series C (7%)
- Series A (7%)
- Series B (7%)
Country Focus
- United States (93%)
- The Netherlands (7%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Bioinformatics
- Test And Measurement
- Pharmaceutical
- Emergency Medicine
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does NYBC Ventures frequently co-invest with?
Which angels does NYBC Ventures often collaborate with?
What are some of recent deals done by NYBC Ventures?
Find More Investors Like NYBC Ventures
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
